Literature DB >> 195372

Reduction of postperfusion cytomegalovirus-infections following the use of leukocyte depleted blood.

D J Lang, P A Ebert, B M Rodgers, H P Boggess, R S Rixse.   

Abstract

After extracorporeal perfusion some patients develop evidence of cytomegalovirus (CMV) infection. It is proposed that antigenically stimulated donor and recipient leukocytes may divide and activate latent CMV associated with leukocytes. To test this hypothesis, alternate patients were perfused with leukocyte-depleted or whole blood (controls). Four of six controls who were CMV antibody negative preoperatively seroconverted after perfusion. Virus was recovered from the blood of three and from the urine of two of these patients. One of four controls who were seropositive preoperatively developed a significant titer rise. Only one of eight patients perfused with leukocyte poor blond who were seronegative prior to surgery developed a viremia and became antibody positive; another manifested a viruria but remained antibody negative. These findings are consistent with the proposed hypothesis and suggest a means for reducing transfusion-associated CMV infections.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 195372     DOI: 10.1046/j.1537-2995.1977.17477216868.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

1.  Cytomegalovirus (CMV) antibody screening in blood donors: modification of new latex agglutination test compared with two standard methods.

Authors:  A Puckett; J E Davis
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

2.  Immunity to human cytomegalovirus measured and compared by complement fixation, indirect fluorescent-antibody, indirect hemagglutination, and enzyme-linked immunosorbent assays.

Authors:  J A Brandt; J D Kettering; J E Lewis
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

3.  Comparative trial of six methods for the detection of CMV antibody in blood donors.

Authors:  A F Hunt; D L Allen; R L Brown; B A Robb; A Y Puckett; C C Entwistle
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

4.  Comparison of five methods of cytomegalovirus antibody screening of blood donors.

Authors:  P H Phipps; L Grégoire; E Rossier; E Perry
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

5.  Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus.

Authors:  J W Gnann; J Ahlmén; C Svalander; L Olding; M B Oldstone; J A Nelson
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

6.  Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection.

Authors:  C Söderberg; S Larsson; S Bergstedt-Lindqvist; E Möller
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products.

Authors:  G P Rice; R D Schrier; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.